文献速递头颈部肿瘤放疗放疗物理与技术

头颈部非黑色素瘤皮肤癌的高剂量率近距离放疗与螺旋断层放疗比较

Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neck.
PubMed 文献 · Radiother Oncol · 2024-12-27

本研究回顾性观察分析了2019至2023年间接受皮肤癌HDR-BT Freiburg flap治疗的患者,为每例患者分别制定个体化HDR-BT表面模和HT计划并比较。共纳入12例患者,HT的靶区覆盖更一致(t检验p<0.05),同侧视神经、视交叉和晶状体的最大剂量及CI更高,放疗医生整体更偏好HT,而HDR-BT在凹面时更受偏好。

要点

  • HT靶区覆盖较HDR-BT更一致,差异有统计学意义(p<0.05)。
  • HT在同侧视神经、视交叉和晶状体的最大剂量及CI更高。
  • 放疗医生整体更偏好HT,凹面时更偏好HDR-BT。

核心结论

  • HT提供更适形的治疗,尽管部分OAR参数在HDR-BT中统计学显著更优,HDR-BT对复杂几何形状可能也更优。

研究设计与样本

  • 回顾性观察分析,纳入2019至2023年间接受皮肤癌HDR-BT Freiburg flap治疗的患者,共12例。
  • 由一名专家放疗肿瘤医生勾画PTV并用不透射线锡丝标记其可见延伸。
  • 每例患者均制定两个治疗计划:个体化HDR-BT表面模和专为本研究计算的HT计划。
  • 对HDR-BT和HT均进行治疗计划质量保证。

主要发现

  • HT较HDR-BT提供更一致的靶区覆盖,t检验差异有统计学意义(p<0.05)。
  • HT在同侧视神经、视交叉和晶状体的CI和最大剂量更高。
  • 放疗医生因HT的PTV覆盖更优(尤其凸面)且保持有效OAR保护而更偏好HT的整体质量。
  • 存在凹面时更偏好HDR-BT。

关键数值与推荐

  • 比较采用OAR最大剂量和适形指数CI。
  • 放疗医生使用其常规工作流程评估计划质量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to investigate and compare High Dose Rate Brachytherapy (HDR-BT) with Helical Tomotherapy (HT) treatment plans. The focus is on small target volumes near radiation-sensitive organs in the ocular region, to evaluate the advantages of these techniques in treating skin cancer. METHODS: This retrospective observational analysis included patients who underwent skin cancer HDR-BT Freiburg flap treatment between 2019 and 2023. An expert radiation oncologist contoured the planning target volumes (PTVs) and marked their visible extension with a radio-opaque tin wire. Each patient had two treatment plans: an individually shaped HDR-BT surface mold and an HT calculation used specifically for this study. Quality assurance of treatment plan was performed in both HDR-BT and HT. The plans were then compared using organ at risk (OAR) maximum doses and the conformity index CI. Radiation oncologists assessed their quality using their routine workflow evaluation plan. RESULTS: Twelve patients were selected for the inclusion in this study. HT provided more consistent target coverage than HDR-BT, with a statistically significant difference (p < 0.05) at t-test. HT showed higher CIs and maximum dose for the optic nerve, optic chiasm, and lens in the homolateral part. Radiation oncologists preferred the overall quality of HT treatment due to its superior PTV coverage, especially for convex surfaces, while maintaining effective OAR sparing. HDR-BT is preferred when concave surfaces are present. CONCLUSION: HT offers more conformal treatment, although some OAR parameters are statistically significantly better with HDR-BT, which may also be superior for complex geometries.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Feliciani G, Licciardello T, Guidi C, et al. Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neck. Radiother Oncol. 2024. PMID: 39733970. doi:10.1016/j.radonc.2024.110703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。